Retrospective Observational Study Using the QOL Scale for Rebamipde Ophthalmic Suspension Treatment in the Dry Eye Syndrome Patient

Retrospective Observational Study Using the QOL Scale for Rebamipde Ophthalmic Suspension Treatment in the Dry Eye Syndrome Patient - Retrospective Observational Study Using the QOL Scale for Rebamipde Ophthalmic Suspension Treatment in the Dry Eye Syndrome Patient

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000024405

Enrollment

Registered

2016-10-18

Start date

2016-10-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Outpatients who be diagnosis of Dry Eye and treat with Rebamipide in Ehime University Hospital from Apr 2013 to Mar 31 2016 2.Patients of 20 years or older at the time of the DEQS interview before the start of therapy

Exclusion criteria

Exclusion criteria: 1.Patients who receive surgical treatment having an influence on cornea and the tear during a investigation period 2.Patients judged by the principal investigator/sub-investigator to be unable to be included in the study

Design outcomes

Primary

Measure	Time frame
Continual change of DEQS	—

Secondary

Measure	Time frame
Correlation of DEQS and Patient Characteristics Correlation of DEQS and Schirmer test or BUT Correlation of DEQS and TSAS-RBUT Correlation of DEQS and keratoconjunctivitis Incidence of side effect	—

Countries

Japan

Contacts

Public ContactYuri Sakane

Ehime University School of Medicine Ophthalmology

y-sakane@m.ehime-u.ac.jp089-960-5361

Outcome results